Single cell sequencing, while a relatively recent development, is opening doors in ours understanding of cell populations and tissues. This article explores how this technology works and what it tells us.

Technology Networks had the pleasure of speaking to Justin Schaal to learn more about MTD12813, its mode of action and how it addresses some of the shortcomings of traditional antibiotics.

In this article, we explore what scanning probe microscopy is, the different forms of the technique, strengths, limitations and applications.

In this article, we will consider how qPCR works, experimental requirements, data analysis and applications of the technique.

In this article, Kevin Boyle explores the current therapeutic landscape for COVID-19.

Sophie Prosolek explores why some vaccines last a lifetime, while others do not, for Technology Networks.

Most vaccine development begins with looking at the pathogen. Scientists pinpoint key residues needed for the virus to enter the body and develop vaccines that train the body to recognize signatures of the foreign invader. Kevin O'Neil Saunders, associate professor of surgery and director of research at the Duke Human Vaccine Institute at Duke University develops vaccines after analyzing the body’s immune response to a pathogen.

Understanding the relationship between cancer and the microbes that call our bodies home could transform the way the disease is managed in the future.

Human skin is an ecosystem for billions of microorganisms that colonize each fold, crease and niche from head to toe. In this article, we describe what the skin microbiome is, which microorganisms are part of the skin microbiome and how we’ve come to understand the various relationships between the human skin and its microbial residents through advanced genomics.

Investment in vaccine science and technology development can provide us with the tools to respond to pathogens with pandemic potential. In this opinion article, Ariana Gomes discusses the use of AI for creating universal vaccines.